Search

Your search keyword '"Whiting, Sam"' showing total 2,509 results

Search Constraints

Start Over You searched for: Author "Whiting, Sam" Remove constraint Author: "Whiting, Sam"
2,509 results on '"Whiting, Sam"'

Search Results

3. First-in-Human Phase I Trial of TPST-1120, an inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

5. Are market giants endangering Australia's live music scene? Industry veterans and local artists are worried.

7. Perioperative Chemotherapy and Chemoradiotherapy for Patients With Resectable and Borderline Resectable Pancreatic Adenocarcinoma

13. South Australian music industry health check: live contemporary music venues and the impact of COVID-19 in 2021

15. Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

16. Supplementary Figure from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

17. Supplementary Data from Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

33. Abstract 1333: Dual blockade of the EP2 and EP4 PGE2 receptors with TPST-1495 is an optimal approach for drugging the prostaglandin pathway

34. A phase 1 study of TPST-1120 as a single agent and in combination with nivolumab in subjects with advanced solid tumors.

35. A phase 1 study of TPST-1495 as a single agent and in combination with pembrolizumab in subjects with solid tumors.

37. Telaglenastat Plus Cabozantinib or Everolimus for Advanced or Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial

44. A Phase I Dose-Escalation and Expansion Study of Telaglenastat in Patients with Advanced or Metastatic Solid Tumors

46. What is 'dynamic pricing' for concert tickets? It can cost you hundreds of dollars while you queue.

48. A phase II randomized study of telaglenastat, a glutaminase (GLS) inhibitor, versus placebo, in combination with pembrolizumab (Pembro) and chemotherapy as first-line treatment for KEAP1/NRF2-mutated non-squamous metastatic non-small cell lung cancer (mNSCLC).

49. The WA government spent $8 million on Coldplay -- but this tourism sugar hit comes at the expense of local music.

50. Australia's music artists are in dire straits -- yet taxpayer-funded Triple J won't shake its commercial flavour.

Catalog

Books, media, physical & digital resources